[HTML][HTML] Early post-transplantation factors predict survival outcomes in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis
Factors predicting allogeneic hematopoietic cell transplantation (HCT) outcomes in
myelofibrosis in the early post-HCT period have not been defined thus far. We attempt to …
myelofibrosis in the early post-HCT period have not been defined thus far. We attempt to …
A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis
R Tamari, DP McLornan, KW Ahn… - Blood …, 2023 - ashpublications.org
To develop a prognostic model for patients undergoing allogeneic hematopoietic cell
transplantation (allo-HCT) for myelofibrosis (MF), we examined the data of 623 patients …
transplantation (allo-HCT) for myelofibrosis (MF), we examined the data of 623 patients …
Determinants of survival in myelofibrosis patients undergoing allogeneic hematopoietic cell transplantation
JC Hernández-Boluda, A Pereira, N Kröger, D Beelen… - Leukemia, 2021 - nature.com
We aimed to evaluate the determinants of survival in myelofibrosis patients undergoing
allogeneic hematopoietic cell transplantation (allo-HCT) and to describe factors predicting …
allogeneic hematopoietic cell transplantation (allo-HCT) and to describe factors predicting …
[HTML][HTML] Dynamic International Prognostic Scoring System scores, pre-transplant therapy and chronic graft-versus-host disease determine outcome after allogeneic …
M Ditschkowski, AH Elmaagacli, R Trenschel… - …, 2012 - ncbi.nlm.nih.gov
Background Myelofibrosis is a myeloproliferative stem cell disorder curable exclusively by
allogeneic hematopoietic stem cell transplantation and is associated with substantial …
allogeneic hematopoietic stem cell transplantation and is associated with substantial …
[HTML][HTML] Predicting survival after allogeneic hematopoietic cell transplantation in myelofibrosis: performance of the Myelofibrosis Transplant Scoring System (MTSS) …
JC Hernández-Boluda, A Pereira… - Biology of Blood and …, 2020 - Elsevier
Accurate prognostic tools are crucial to assess the risk/benefit ratio of allogeneic
hematopoietic cell transplantation (allo-HCT) in patients with myelofibrosis (MF). We aimed …
hematopoietic cell transplantation (allo-HCT) in patients with myelofibrosis (MF). We aimed …
Outcomes following second allogeneic haematopoietic cell transplantation in patients with myelofibrosis: a retrospective study of the Chronic Malignancies Working …
Therapeutic management of patients with primary or secondary myelofibrosis (MF) who
experience relapse or graft failure following allogeneic haematopoietic cell transplantation …
experience relapse or graft failure following allogeneic haematopoietic cell transplantation …
Survival following allogeneic transplant in patients with myelofibrosis
Allogeneic hematopoietic cell transplantation (HCT) is the only curative therapy for
myelofibrosis (MF). In this large multicenter retrospective study, overall survival (OS) in MF …
myelofibrosis (MF). In this large multicenter retrospective study, overall survival (OS) in MF …
[HTML][HTML] Association of factors influencing selection of upfront hematopoietic cell transplantation versus nontransplantation therapies in myelofibrosis
E Smith, J Huang, A Viswabandya, D Maze… - … and Cellular Therapy, 2021 - Elsevier
Despite the curative potential of allogeneic hematopoietic cell transplantation (HCT) for
myelofibrosis (MF), a significant number of patients with MF do not undergo HCT. Factors …
myelofibrosis (MF), a significant number of patients with MF do not undergo HCT. Factors …
[HTML][HTML] International Working Group scores predict post-transplant outcomes in patients with myelofibrosis
BL Scott, TA Gooley, ML Linenberger, BM Sandmaier… - Blood, 2010 - Elsevier
Abstract Abstract 3085 The International Working Group (IWG) has determined that
prognosis in myelofibrosis is predicted by a scoring system that includes the following …
prognosis in myelofibrosis is predicted by a scoring system that includes the following …
[HTML][HTML] Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
M Robin, LC De Wreede, C Wolschke, J Schetelig… - …, 2019 - ncbi.nlm.nih.gov
Allogeneic hematopoietic stem cell transplant remains the only curative treatment for
myelofibrosis. Most post-transplantation events occur during the first two years and hence …
myelofibrosis. Most post-transplantation events occur during the first two years and hence …